Glenmede Trust’s Labcorp LH Stock Holding History

Glenmede Trust’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$69.6M	Sell	261,012 -5,218	-2%	-$1.41M	0.34%	63
2025 Q4	$66.8M	Buy	+266,230	New	+$70.7M	0.32%	69
2025 Q1	$65.8M	Sell	282,856 -3,627	-1%	-$880K	0.35%	66
2024 Q4	$65.7M	Sell	286,483 -8,871	-3%	-$2.04M	0.34%	72
2024 Q3	$66M	Buy	295,354 +2,949	+1%	+$648K	0.32%	75
2024 Q2	$59.5M	Sell	292,405 -8,372	-3%	-$1.7M	0.3%	79
2024 Q1	$65.7M	Buy	300,777 +67	+0%	+$14.8K	0.33%	76
2023 Q4	$68.3M	Sell	300,710 -643	-0.2%	-$135K	0.35%	73
2023 Q3	$60.6M	Sell	301,353 -47,570	-14%	-$10M	0.35%	72
2023 Q2	$68.8M	Hold	348,923	–	–	0.39%	63
2023 Q1	$68.8M	Sell	348,923 -6,187	-2%	-$1.27M	0.39%	63
2022 Q4	$71.8M	Sell	355,110 -5,105	-1%	-$998K	0.42%	64
2022 Q3	$63.4M	Sell	360,215 -5,418	-1%	-$1.11M	0.4%	64
2022 Q2	$73.6M	Sell	365,633 -2,160	-0.6%	-$460K	0.43%	59
2022 Q1	$83.3M	Buy	367,793 +3,198	+0.9%	+$752K	0.41%	58
2021 Q4	$98.4M	Sell	364,595 -687	-0.2%	-$170K	0.47%	46
2021 Q3	$88.3M	Sell	365,282 -3,599	-1%	-$907K	0.46%	49
2021 Q2	$87.4M	Sell	368,881 -977	-0.3%	-$223K	0.45%	48
2021 Q1	$81M	Sell	369,858 -5,268	-1%	-$1.06M	0.44%	57
2020 Q4	$65.6M	Sell	375,126 -3,473	-0.9%	-$600K	0.36%	77
2020 Q3	$61.2M	Sell	378,599 -2,346	-0.6%	-$372K	0.37%	77
2020 Q2	$54.4M	Buy	380,945 +199	+0.1%	+$27.5K	0.33%	87
2020 Q1	$55.3M	Hold	380,746	–	–	0.25%	109
2019 Q4	$55.3M	Sell	380,746 -10,497	-3%	-$1.52M	0.25%	109
2019 Q3	$56.5K	Buy	391,243 +5,339	+1%	+$779K	0.26%	109
2019 Q2	$57.3K	Buy	385,904 +4,277	+1%	+$597K	0.25%	110
2019 Q1	$50.2K	Buy	381,627 +47,696	+14%	+$5.88M	0.23%	124
2018 Q4	$36.2K	Sell	333,931 -26,513	-7%	-$3.55M	0.18%	169
2018 Q3	$53.8M	Sell	360,444 -64	-0%	-$9.73K	0.22%	129
2018 Q2	$55.6M	Buy	360,508 +59,519	+20%	+$8.98M	0.25%	108
2018 Q1	$41.2M	Hold	300,989	–	–	0.17%	183
2017 Q4	$41.2M	Buy	300,989 +26,704	+10%	+$3.53M	0.17%	183
2017 Q3	$35.6M	Sell	274,285 -3,058	-1%	-$408K	0.16%	208
2017 Q2	$34.2M	Hold	277,343	–	–	0.16%	199
2017 Q1	$34.2M	Sell	277,343 -6,628	-2%	-$785K	0.16%	199
2016 Q4	$31.3M	Buy	283,971 +8,539	+3%	+$949K	0.17%	211
2016 Q3	$32.5M	Buy	275,432 +993	+0.4%	+$117K	0.18%	178
2016 Q2	$30.7M	Buy	274,439 +10,519	+4%	+$1.13M	0.19%	184
2016 Q1	$26.6M	Sell	263,920 -119,900	-31%	-$11.5M	0.17%	203
2015 Q4	$40.8M	Sell	383,820 -1,833	-0.5%	-$189K	0.28%	89
2015 Q3	$35.9M	Sell	385,653 -3,905	-1%	-$404K	0.26%	104
2015 Q2	$40.6M	Sell	389,558 -136,754	-26%	-$14.2M	0.29%	86
2015 Q1	$57M	Sell	526,312 -40,266	-7%	-$4.14M	0.42%	47
2014 Q4	$52.5M	Buy	566,578 +320,621	+130%	+$28.3M	0.41%	45
2014 Q3	$21.5M	Buy	245,957 +4,696	+2%	+$424K	0.19%	158
2014 Q2	$21.2M	Buy	241,261 +174,123	+259%	+$15.1M	0.19%	139
2014 Q1	$5.66M	Sell	67,138 -55,182	-45%	-$4.4M	0.05%	390
2013 Q4	$9.6M	Sell	122,320 -1,384	-1%	-$118K	0.1%	274
2013 Q3	$10.5M	Sell	123,704 -4,321	-3%	-$364K	0.13%	213
2013 Q2	$11M	Buy	+128,025	New	+$10.6M	0.14%	152

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Glenmede Trust's LH Position: Q1 2026 in Review

Glenmede Trust reduced its Labcorp (LH) stake by 2% in Q1 2026, selling an estimated $1.41M and leaving 261,012 shares worth $69.6M. The position accounts for 0.34% of the portfolio, ranked #63.

Glenmede Trust first reported a position in LH in Q2 2013 and has held it in 50 quarters since. The position peaked at $98.4M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Glenmede Trust held 261,012 shares of Labcorp worth $69.6M as of Q1 2026.
Glenmede Trust sold 5,218 Labcorp shares in Q1 2026, an estimated $1.41M.
Labcorp made up 0.34% of Glenmede Trust's portfolio in Q1 2026, its #63 holding.
Glenmede Trust first reported a position in Labcorp in Q2 2013 and has held it in 50 quarters since.
Glenmede Trust's Labcorp position peaked at $98.4M in Q4 2021.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.